human | Q5 |
P496 | ORCID iD | 0000-0002-9089-8605 |
P27 | country of citizenship | Sweden | Q34 |
P108 | employer | University of Gothenburg | Q371522 |
P735 | given name | Marie | Q632104 |
Marie | Q632104 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | female | Q6581072 |
Q46894750 | 17Beta-estradiol expands IgA-producing B cells in mice deficient for the mu chain |
Q43180968 | Amelioration of collagen-induced arthritis and immune-associated bone loss through signaling via estrogen receptor alpha, and not estrogen receptor beta or G protein-coupled receptor 30. |
Q35557927 | Combined treatment with dexamethasone and raloxifene totally abrogates osteoporosis and joint destruction in experimental postmenopausal arthritis |
Q55493662 | ERα expression in T lymphocytes is dispensable for estrogenic effects in bone. |
Q60194294 | Effects of oestradiol and raloxifene on the induction and effector phases of experimental postmenopausal arthritis and secondary osteoporosis |
Q46102174 | Elevated aromatase expression in osteoblasts leads to increased bone mass without systemic adverse effects |
Q61480223 | Enzalutamide Reduces the Bone Mass in the Axial But Not the Appendicular Skeleton in Male Mice |
Q36245810 | Estradiol ameliorates arthritis and protects against systemic bone loss in Staphylococcus aureus infection in mice |
Q35734814 | Estrogen receptor-α expression in neuronal cells affects bone mass |
Q36598181 | Estrogen receptor-α in osteocytes is important for trabecular bone formation in male mice |
Q36619427 | Estrogen receptor-α is required for the osteogenic response to mechanical loading in a ligand-independent manner involving its activation function 1 but not 2. |
Q35164919 | Estrogen regulates T helper 17 phenotype and localization in experimental autoimmune arthritis |
Q37777882 | Estrogens in rheumatoid arthritis; the immune system and bone |
Q50242372 | Exosomal secretion of death bullets: a new way of apoptotic escape? |
Q37612772 | Extra-nuclear effects of estrogen on cortical bone in males require ERαAF-1. |
Q37139368 | Female Mice Lacking Estrogen Receptor-α in Hypothalamic Proopiomelanocortin (POMC) Neurons Display Enhanced Estrogenic Response on Cortical Bone Mass |
Q50977377 | IL-17-producing γδT cells are regulated by estrogen during development of experimental arthritis. |
Q43276896 | In vivo activation of gene transcription via oestrogen response elements by a raloxifene analogue |
Q61480161 | Increased bone mass in a mouse model with low fat mass |
Q51741084 | Inducible Wnt16 inactivation: WNT16 regulates cortical bone thickness in adult mice. |
Q28511248 | Liver-derived IGF1 enhances the androgenic response in prostate |
Q46627659 | Long-term anti-arthritic and anti-osteoporotic effects of raloxifene in established experimental postmenopausal polyarthritis |
Q51035725 | Measurement of a Comprehensive Sex Steroid Profile in Rodent Serum by High-Sensitive Gas Chromatography-Tandem Mass Spectrometry. |
Q33661693 | Periarticular bone loss in antigen-induced arthritis |
Q21135319 | Reduced bone mass and muscle strength in male 5α-reductase type 1 inactivated mice |
Q39080492 | Regulation of bone growth via ligand-specific activation of estrogen receptor alpha |
Q57623455 | Role of Androgen and Estrogen Receptors for the Action of Dehydroepiandrosterone (DHEA) |
Q33772317 | Role of endogenous and exogenous female sex hormones in arthritis and osteoporosis development in B10.Q-ncf1*/* mice with collagen-induced chronic arthritis |
Q46973407 | Role of raloxifene as a potent inhibitor of experimental postmenopausal polyarthritis and osteoporosis |
Q49644971 | Roles of activating functions 1 and 2 of estrogen receptor α in lymphopoiesis |
Q34794486 | Roles of transactivating functions 1 and 2 of estrogen receptor-alpha in bone. |
Q37070860 | SERMs have substance-specific effects on bone, and these effects are mediated via ERαAF-1 in female mice |
Q34437537 | Sex steroid actions in male bone |
Q36354870 | The bone-sparing effects of estrogen and WNT16 are independent of each other |
Q34295211 | The effect of estrogen on bone requires ERα in nonhematopoietic cells but is enhanced by ERα in hematopoietic cells |
Q37519748 | The estrogen receptor antagonist ICI 182,780 can act both as an agonist and an inverse agonist when estrogen receptor α AF-2 is modified |
Q36153190 | The gut microbiota regulates bone mass in mice |
Q36780852 | The role of activation functions 1 and 2 of estrogen receptor-α for the effects of estradiol and selective estrogen receptor modulators in male mice |
Q43011729 | The role of estrogen receptor α in growth plate cartilage for longitudinal bone growth |
Q38091660 | The role of estrogen receptor α in the regulation of bone and growth plate cartilage. |
Q36041866 | The role of estrogen receptor-α and its activation function-1 for growth plate closure in female mice |
Q37076717 | The role of membrane ERα signaling in bone and other major estrogen responsive tissues |
Q46195070 | The role of the G protein-coupled receptor GPR30 in the effects of estrogen in ovariectomized mice |
Q34480349 | The role of total and cartilage-specific estrogen receptor alpha expression for the ameliorating effect of estrogen treatment on arthritis |
Q35888892 | Trabecular bone loss in collagen antibody-induced arthritis. |
Q99593947 | Vitamin D3 receptor polymorphisms regulate T cells and T cell-dependent inflammatory diseases |
Search more.